COVID-19 Is Wake-Up Call For Europe's Complacency Over Influenza
Roche CEO Speaks Out
The coronavirus outbreak shows how vulnerable vast numbers of people remain to potentially deadly viruses. Roche boss Severin Schwan believes that the lessons being learnt about COVID-19 should be applied to tackling flu.
You may also be interested in...
The coronavirus pandemic has not had much impact to date on Roche's operations and first-quarter sales grew nicely. However, CEO Severin Schwan hopes certain countries will learn the lesson about not being prepared.
Xofluza is also the first non-cancer drug to be reviewed under the Australia-Canada-Singapore-Switzerland (ACSS) Consortium’s work-sharing initiative.
Shionogi’s novel single-dose flu drug shows promise in first Phase III results in post-exposure prevention, paving the way for a Japanese filing in this setting and potentially expanding already healthy sales.